Fatty liver disease

I start my day every morning by swallowing a handful of pills with water I keep on my nightstand. It has been this way for…

Treatment with Wegovy (semaglutide) showed a consistent safety and efficacy profile across a range of patient subgroups with metabolic dysfunction-associated steatohepatitis (MASH), a serious…

Today, I sat down to go over my upcoming summer doctor appointments because ’tis the season for my annual upper and lower gastrointestinal scopes and…

Long before I ever set foot inside my gastroenterologist’s office to discuss my liver health and metabolic dysfunction-associated steatohepatitis (MASH), I was diagnosed with…

Belapectin, Galectin Therapeutics’ investigational therapy, significantly reduced the development of new enlarged blood vessels in the esophagus among people with metabolic dysfunction-associated steatohepatitis (MASH),…

Your liver may store excess fat when you’re living with metabolic dysfunction-associated steatohepatitis (MASH), but does it also store secrets you’re keeping from your…

Madrigal Pharmaceuticals has secured worldwide rights to develop ARO-PNPLA3, an experimental treatment created by Arrowhead Pharmaceuticals for people with metabolic dysfunction-associated steatohepatitis (MASH),…

The email wasn’t unexpected. Earlier in the week, I had received a call from my transplant coordinator at one of the two hospitals where I’m…

A once-monthly investigational therapy for metabolic dysfunction-associated steatohepatitis (MASH), called efimosfermin, has earned two new regulatory designations — one in the U.S. and the other…

One of the things I’ve been most grateful for over the past few years is simple: I’m not as sick as I once was. When…